Association International Extranodal Lymphoma Study Group (IELSG)

Extranodal marginal zone lymphoma is a major area of interest for the Association International Extranodal Lymphoma Study Group (IELSG), with studies focused on disease control in extranodal sites and on treatment options for newly diagnosed, relapsed, and refractory cases. The research portfolio includes MALT lymphoma and other extranodal presentations requiring systemic therapy.

• Rituximab-based therapy
• BTK inhibitors
• Relapsed or refractory disease

Clinical activity also extends to first-line treatment strategies and maintenance approaches in extranodal disease.